These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 11086089)

  • 41. Identification of a common HLA-DP4-restricted T-cell epitope in the conserved region of the respiratory syncytial virus G protein.
    de Waal L; Yüksel S; Brandenburg AH; Langedijk JP; Sintnicolaas K; Verjans GM; Osterhaus AD; de Swart RL
    J Virol; 2004 Feb; 78(4):1775-81. PubMed ID: 14747542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus.
    Bastien N; Trudel M; Simard C
    Virology; 1997 Jul; 234(1):118-22. PubMed ID: 9234952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide.
    Corvaïa N; Tournier P; Nguyen TN; Haeuw JF; Power UF; Binz H; Andréoni C
    J Infect Dis; 1997 Sep; 176(3):560-9. PubMed ID: 9291300
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection.
    Hussell T; Georgiou A; Sparer TE; Matthews S; Pala P; Openshaw PJ
    J Immunol; 1998 Dec; 161(11):6215-22. PubMed ID: 9834108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
    Céspedes PF; Rey-Jurado E; Espinoza JA; Rivera CA; Canedo-Marroquín G; Bueno SM; Kalergis AM
    Vaccine; 2017 Feb; 35(5):757-766. PubMed ID: 28065474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of Novel Respiratory Syncytial Virus CD4
    Schmidt ME; Varga SM
    Immunohorizons; 2019 Jan; 3(1):1-12. PubMed ID: 31356172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection.
    Lee S; Miller SA; Wright DW; Rock MT; Crowe JE
    J Virol; 2007 Mar; 81(5):2349-58. PubMed ID: 17182672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RSV recombinant candidate vaccine G1F/M2 with CpG as an adjuvant prevents vaccine-associated lung inflammation, which may be associated with the appropriate types of immune memory in spleens and lungs.
    Li N; Zhang L; Zheng B; Li W; Liu J; Zhang H; Zeng R
    Hum Vaccin Immunother; 2019; 15(11):2684-2694. PubMed ID: 31021703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD40 ligand (CD154) enhances the Th1 and antibody responses to respiratory syncytial virus in the BALB/c mouse.
    Tripp RA; Jones L; Anderson LJ; Brown MP
    J Immunol; 2000 Jun; 164(11):5913-21. PubMed ID: 10820273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of multiple HLA-DR-restricted epitopes of the tumor-associated antigen CAMEL by CD4+ Th1/Th2 lymphocytes.
    Slager EH; van der Minne CE; Krüse M; Krueger DD; Griffioen M; Osanto S
    J Immunol; 2004 Apr; 172(8):5095-102. PubMed ID: 15067093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Jug r 2-reactive CD4(+) T cells have a dominant immune role in walnut allergy.
    Archila LD; Jeong D; Pascal M; Bartra J; Juan M; Robinson D; Farrington ML; Kwok WW
    J Allergy Clin Immunol; 2015 Oct; 136(4):983-92.e7. PubMed ID: 25772597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential antigen sensitivity and costimulatory requirements in human Th1 and Th2 antigen-specific CD4+ cells with similar TCR avidity.
    Holzer U; Kwok WW; Nepom GT; Buckner JH
    J Immunol; 2003 Feb; 170(3):1218-23. PubMed ID: 12538679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD4 T cells selected by antigen under Th2 polarizing conditions favor an elongated TCR alpha chain complementarity-determining region 3.
    Boyton RJ; Zaccai N; Jones EY; Altmann DM
    J Immunol; 2002 Feb; 168(3):1018-27. PubMed ID: 11801634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human Epitopes Identified from Herpes Simplex Virus Tegument Protein VP11/12 (UL46) Recall Multifunctional Effector Memory CD4
    Srivastava R; Coulon PA; Prakash S; Dhanushkodi NR; Roy S; Nguyen AM; Alomari NI; Mai UT; Amezquita C; Ye C; Maillère B; BenMohamed L
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31915285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic T cells.
    Kulkarni AB; Morse HC; Bennink JR; Yewdell JW; Murphy BR
    J Virol; 1993 Jul; 67(7):4086-92. PubMed ID: 7685408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains.
    Lee J; Klenow L; Coyle EM; Golding H; Khurana S
    PLoS Pathog; 2018 Aug; 14(8):e1007262. PubMed ID: 30142227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fully functional HLA B27-restricted CD4+ as well as CD8+ T cell responses in TCR transgenic mice.
    Roddis M; Carter RW; Sun MY; Weissensteiner T; McMichael AJ; Bowness P; Bodmer HC
    J Immunol; 2004 Jan; 172(1):155-61. PubMed ID: 14688321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection.
    Hussell T; Baldwin CJ; O'Garra A; Openshaw PJ
    Eur J Immunol; 1997 Dec; 27(12):3341-9. PubMed ID: 9464822
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunodominant T-cell epitope on the F protein of respiratory syncytial virus recognized by human lymphocytes.
    Levely ME; Bannow CA; Smith CW; Nicholas JA
    J Virol; 1991 Jul; 65(7):3789-96. PubMed ID: 1710289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chimeric virus-like particles containing a conserved region of the G protein in combination with a single peptide of the M2 protein confer protection against respiratory syncytial virus infection.
    Qiao L; Zhang Y; Chai F; Tan Y; Huo C; Pan Z
    Antiviral Res; 2016 Jul; 131():131-40. PubMed ID: 27154395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.